DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Tolvaptan
Tolvaptan
Long-Term Administration of Tolvaptan to Patients with Decompensated
Subject: Samsca (Tolvaptan) Original Effective Date: 07/27/15
Jynarque Pi
Addition of Tolvaptan Compared with Increased Dose of Furosemide in Heart Failure Patients with Chronic Kidney Disease Under Furosemide Treatment
New Approaches of the Hyponatremia Treatment in the Elderly – an Update
Tolvaptan Therapy of Chinese Cirrhotic Patients with Ascites After
Optimal Diuretic Strategies in Heart Failure
204441Orig1s000
2019 Prohibited List
Tolvaptan (JYNARQUE) Criteria for Use August 2018
Clinical Commissioning Policy: Tolvaptan for Hyponatraemia
Custom-Drug-List-Formulary.Pdf
Perioperative Medication Management - Adult/Pediatric - Inpatient/Ambulatory Clinical Practice Guideline
THE USE of VAPTANS in HYPONATRAEMIA Corinna Giuliani, *Alessandro Peri
The Effect of Trichlormethiazide in Autosomal Dominant Polycystic
Long-Term Use of Demeclocycline for the Treatment of Chronic Hyponatremia
Guidelines for the Assessment and Management of Hyponatraemia
Management of Liver Cirrhosis in Patients with Hepatocellular Carcinoma
Top View
Fluids and Diuretics
California 3 Tier with Specialty Drug List
Treatment of Hyponatremia with Acetazolamide in Cardiovascular Patients: Possible Alternative Diuretic to Vasopressin Antagonists
Drugs Involved in Significant Pharmacokinetic Drug-Drug Interactions in 2015
FEP 5 Tier Rx Drug Formulary (607) Standard Option
Case Report: a Thiazide Diuretic to Treat Polyuria Induced by Tolvaptan
Complete Drug List (Formulary) 2021
AQUARESIS UTILITY for HYPONATREMIC ACUTE HEART FAILURE (AQUA-AHF) STUDY Protocol #: HS-13-00705 Phase IV
Assessment Report
Preferred Drug List
VA/Dod CLINICAL PRACTICE GUIDELINE for the MANAGEMENT of CHRONIC KIDNEY DISEASE
Free PDF Download
Regional Variance of the Early Use of Tolvaptan for Autosomal Dominant Polycystic Kidney Disease
Samsca, INN-Tolvaptan
Ambetter 2020 Prescription Drug List
Rational Management of Hospitalized Patients with Hyponatremia: Application to Patient Cases
Absorption, Distribution, Metabolism and Excretion (ADME) 62, 399, 400 Accelerating I
The Treatment of Vasopressin V2-Receptor Antagonists in Cirrhosis Patients with Ascites
12Th International ISSX Meeting 28‒31 July 2019 Portland, Oregon
7-Renal Drugs FINAL
Management of Cirrhotic Ascites Under the Add-On Administration of Tolvaptan
Role of Diuretics and Ultrafiltration in Congestive Heart Failure
Kidney Intercalated Cells and the Transcription Factor Foxi1 Drive Cystogenesis in Tuberous Sclerosis Complex
Drug Treatment of Congestive Heart Failure
Suffolk Drug & Therapeutics Group
Effects of Tolvaptan in Patients with Chronic Kidney Disease and Chronic Heart Failure
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Utility of Spherical Human Liver Microtissues for Prediction of Clinical Drug‑Induced Liver Injury
Pharmacology/Therapeutics I Block Iv Handouts – 2017-18
Vasopressin Receptor Antagonist, Tolvaptan, for Treating Hyponatremia in Patients with Heart Failure
Four Years of Tolvaptan: Experience from Two Large Teaching Hospitals
Clinical Drug List - September 2021
BMH Medical Journal 2015;2(4):106-109 Brief Review Vaptans
Australian Public Assessment Report for Tolvaptan
Acetazolamide As a Potent Chloride-Regaining Diuretic: Short
Tolvaptan for Fluid Management in Living Donor Liver Transplant
When Is It Appropriate to Use Vasopressin Receptor Antagonists?
Concept ID Name Class 1319998 Acebutolol Adrenergics 1154343
Effects of Tolvaptan in Patients with Chronic Kidney Disease And
Drugs That Can Affect Blood Glucose Levels Generic Name (Brand Name)
Effects of Low-Dose Tolvaptan on Electrolyte Abnormality and Hemodynamic Parameters in a Liver Cirrhosis-Associated Portopulmonary Hypertension Patient: a Case Report
DIGOXIN ORAL SOLUTION Safely and Effectively
East of England Priorities Advisory Committee a Function Of
SAMSCA (Tolvaptan) Is Available in 15 Mg and 30 Mg Tablets [See How Supplied/Storage and Handling (16)]
Jasn2712editorial 3499..3510
Short Term Efficacy and Safety of Low Dose Tolvaptan in Patients With
Early Administration of Tolvaptan Can Improve Survival in Patients with Cirrhotic Ascites